Diff Profiles › MTBLS127_0005_00000027

HepG2_0uM_vs_HepG2_200uM

HepG2_0uM vs HepG2_200uM

p-value ≤ 0.05 38 significant 2025-09-26 00:00:00 Study: MTBLS127
81 Total Features
38 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS127_0005_00000027
Linked study
MTBLS127 — Resveratrol metabolism in HepG2 (human hepatocytes), HaCaT (human keratinocytes), and C2C12 (mouse myoblasts)
Comparison
HepG2_0uM vs HepG2_200uM
Group A
HepG2 cells with 0 µM Resveratrol. Baseline group for comparison with treated HepG2 samples.
Group B
HepG2 cells with 200 µM Resveratrol. Represents high concentration treatment effect in HepG2 cells.
Total features tested
81
Significant features
38
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
QWSAYEBSTMCFKY-OTPOQTMVSA-N (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-hydroxy-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy]oxane-2-carboxylic acid down 1e-06 2.37e-06
QWSAYEBSTMCFKY-BMPGWQKJSA-N 3-hydroxy-5-[(Z)-2-(4-hydroxyphenyl)ethenyl]phenyl β-D-glucopyranosiduronic acid down 1e-06 0.000197
LUKBXSAWLPMMSZ-OWOJBTEDSA-N RESVERATROL down 7.924e-05 0.0141
ISAKRJDGNUQOIC-UHFFFAOYSA-N Urazil up 10.74 1.44e-06
UHDGCWIWMRVCDJ-XVFCMESISA-N 4-amino-1-β-<small>D</small>-ribofuranosylpyrimidin-2(1<em>H</em>)-one down 0.06667 9.68e-06
RQFCJASXJCIDSX-UUOKFMHZSA-N GMP down 0.1534 0.0005
XOHUEYCVLUUEJJ-UWTATZPHSA-N 2,3-Disphospho-D-glycerate up 2.911 1.75e-06
QIAFMBKCNZACKA-UHFFFAOYSA-N Benzamidoessigsäure down 0.3243 1.52e-05
MVMSCBBUIHUTGJ-ZQVROCHNSA-N GDP-glucose down 0.2912 5.16e-05
HDYANYHVCAPMJV-LXQIFKJMSA-N UDP-alpha-D-glucuronate up 3.246 0.000104